Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients-Reference-Cited by-同舟云学术

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients

Published:2013-09-19 Issue:23 Volume:119 Page:4162-4169
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Canner Jason¹,Alonzo Todd A.²,Franklin Janet³,Freyer David R.⁴,Gamis Alan⁵,Gerbing Robert B.²,Lange Beverly J.⁶,Meshinchi Soheil⁷,Woods William G.⁸,Perentesis John⁹,Horan John⁸

Affiliation:

1. Advocate Hope Children's Hospital; Oak Lawn Illinois

2. University of Southern California; Los Angeles California

3. Children's Oncology Group; Consultant

4. Children's Hospital Los Angeles; Los Angeles California

5. Children's Mercy Hospitals and Clinics; Kansas City Missouri

6. Children's Hospital of Philadelphia; Philadelphia Pennsylvania

7. Fred Hutchinson Cancer Research Center; Seattle Washington

8. Aflac Cancer and Blood Disorders Center; Emory University/Children's Healthcare of Atlanta; Atlanta Georgia

9. Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28342/fullpdf

Reference21 articles.

1. Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421;Becton;Blood.,2006

2. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group;Cooper;Cancer.,2012

3. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98;Creutzig;J Clin Oncol.,2006

4. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group;Lange;Blood.,2008

5. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia;Webb;Blood.,2001

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of body mass index at diagnosis on outcomes of pediatric acute leukemia: A systematic review and meta-analysis;PLOS ONE;2024-05-06

2. Treatment Outcomes of Adolescents Compared to Younger Pediatric Patients with Acute Myeloid Leukemia: Do They Need a Special Approach?;Cancers;2024-03-14

3. AML in Distinct Age-Defined Populations of Infants, Adolescents and Young Adults;Pediatric Oncology;2024

4. Prevalence of Adverse Event Reporting in Adolescents and Young Adults Enrolled in Cancer Clinical Trials;JCO Oncology Practice;2023-11

5. Risk of early death in adolescents and young adults with cancer: a population-based study;JNCI: Journal of the National Cancer Institute;2023-01-23